The beneficial effects of amineptine (Survector 100) in the treatment of depression: preliminary results of an Indian multicenter trial
Boral GC, Shah LP
University Medical College,
Calcutta, India.
Clin Neuropharmacol 1989; 12 Suppl 2:S51-7


A multicenter study of the efficacy and safety of amineptine in the treatment of depression has been performed in India. Patients fulfilling the DSM-III criteria for depression were included in this open clinical trial and treated with amineptine for 6 weeks. They received one 100-mg tablet or two (100 mg) tablets of amineptine per day. Efficacy of treatment was assessed using the Hamilton Depression Rating scale on D0, D7, D14, D21, D35, and D42. Liver function and cardiovascular function were examined on D0 and D42 to assess possible adverse effect of treatment. The preliminary results in 32 patients showed that amineptine was effective as soon as the 7th day of treatment and that this effect improved continuously throughout the study. Amineptine was found to be safe.
Amineptine: Italy
Amineptine excess
Amineptine and sex
Mesolimbic dopamine
Amineptine in Portugal
Amineptine in Sri Lanka
Amineptine and smart mice
Canine compulsive disorder
Amineptine and unipolar depression

and further reading

Future Opioids
BLTC Research
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family